Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-19-017078
Filing Date
2019-01-25
Accepted
2019-01-25 16:11:07
Documents
7
Period of Report
2019-03-14
Effectiveness Date
2019-01-25

Document Format Files

Seq Description Document Type Size
1 DEF 14A d687022ddef14a.htm DEF 14A 1033729
2 GRAPHIC g687022g00b41.jpg GRAPHIC 107060
3 GRAPHIC g687022g27e04.jpg GRAPHIC 54665
4 GRAPHIC g687022g41x72.jpg GRAPHIC 30346
5 GRAPHIC g687022g53g40.jpg GRAPHIC 301956
6 GRAPHIC g687022g62t22.jpg GRAPHIC 50524
7 GRAPHIC g687022g70d20.jpg GRAPHIC 68095
  Complete submission text file 0001193125-19-017078.txt   1879784
Mailing Address 225 SOUTH LAKE AVENUE SUITE 1050 PASADENA CA 91101
Business Address 225 SOUTH LAKE AVENUE SUITE 1050 PASADENA CA 91101 626-304-3400
ARROWHEAD PHARMACEUTICALS, INC. (Filer) CIK: 0000879407 (see all company filings)

EIN.: 460408024 | State of Incorp.: DE | Fiscal Year End: 0930
Type: DEF 14A | Act: 34 | File No.: 001-38042 | Film No.: 19542669
SIC: 2834 Pharmaceutical Preparations